Xi'an, China

Chuanyang Xu

This inventor holds 1 USPTO granted patent. Top assignee: The Fourth Military Medical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuanyang Xu. Retrieved from https://idiyas.com/inventor/chuanyang-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chuanyang Xu

Introduction

Chuanyang Xu is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies. His work is recognized for its potential impact on therapeutic applications.

Latest Patents

Chuanyang Xu holds a patent for an "ANTI-GDF15 NEUTRALIZING MONOCLONAL ANTIBODY AND USE THEREOF." This innovative patent addresses important medical challenges and showcases his expertise in antibody development. He has 1 patent to his name, reflecting his commitment to advancing medical science.

Career Highlights

Xu is affiliated with The Fourth Military Medical University, where he conducts research and collaborates with other experts in the field. His role at the university allows him to contribute to various projects aimed at improving healthcare solutions.

Collaborations

Throughout his career, Chuanyang Xu has worked alongside talented colleagues, including Yingqi Zhang and Meng Li. These collaborations have fostered a productive research environment and have led to advancements in their shared field of study.

Conclusion

Chuanyang Xu's contributions to medical research through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to inspire advancements in therapeutic applications and showcases the potential of monoclonal antibodies in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…